NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Wednesday, May 31st

Today's Agenda

8:15AM-9AM

Presidential Lecture: Aging in MS
Faculty: Jennifer Graves, MD, PhD, MAS

9:15AM-12:15PM

Fundamentals of MS Care
PART 1: The History of MS, Diagnosing the Disease and Managing Specific Populations
Various Faculty

9:15AM-12:15PM

Current Topics and Trends in MS Rehab:
PART 1: Understanding Fatigue and its Clinical Management
Various faculty

9:15AM-12:15PM

Symposia:
The Role of Serum Biomarkers in the Management of MS
Various faculty

9:15AM-12:15PM

Symposia:
From Every Crisis Comes Opportunity: Managing Our Mood and Burnout in Medicine
Various faculty

9:15AM-12:15PM

Symposia:
Tackling Health Disparities in MS: A Multidisciplinary Approach
Various faculty

11:30AM-2:45PM

Exhibit Hall Open
Lunch served from 12:15PM-1:45PM

3:00PM-5:00PM

Platforms:
Disease-Modifying Therapies

Disease Management

Imaging

Psychosocial

Rehabilitation

4:30PM-7:45PM

Exhibit Hall Open
Dinner served 5:00PM-7:00PM

5:15PM-7:15PM

Poster Session

7:45PM-10:00PM

Giants of Multiple Sclerosis Awards Ceremony

CMSC Highlights from Wednesday, May 31st

MS Misdiagnosis Is Still a Problem, But Promising Biomarkers May Be Part of the Solution

June 1st 2023

Andrew Solomon, MD, discussed inherent biases affecting MS diagnosis and how advances in imaging may help curb diagnostic errors.

Ublituximab Outperforms Teriflunomide in Improving Fatigue in Multiple Sclerosis

June 1st 2023

Over the 96-week treatment period, ublituximab-treated patients outperformed teriflunomide-treated patients on several domains of the Fatigue Impact Scale.

Multiple Sclerosis Onset Begins Significantly Earlier in Latinx Patients

May 31st 2023

Despite similar proportion of females and ever-smokers, age of onset of multiple sclerosis was significantly earlier for Latinx patients compared with White non-Latinx individuals.

Low-Fat Diet Intervention Demonstrates Significant Impact on Multiple Sclerosis Fatigue

May 31st 2023

Investigators observed significant decreases in Modified Fatigue Impact Scale and Fatigue Severity Scale with the low-fat diet in relation to controls.

^© 2023, Consortium of Multiple Sclerosis Centers and MJH Life Sciences. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, or Sanofi.